Introduction of a Toric Intraocular Lens to a Non-Refractive Cataract Practice: Challenges and Outcomes
Clare Kirwan1, John M Nolan2, Jim Stack2
1Biomedical Science Research Institute, University of Ulster, Coleraine, Northern Ireland; Institute of Eye Surgery, and Institute of Vision Research, Whitfield Clinic, Cork Road, Waterford, Ireland; Macular Pigment Research Group, Waterford Institute of Technology, Waterford, Ireland.
Summary
Introducing toric intraocular lenses (IOLs) in non-refractive cataract surgery significantly reduces post-operative astigmatism compared to non-toric IOLs. This leads to high patient satisfaction and minimal visual disturbances.
Area of Science:
- Ophthalmology
- Biomedical Engineering
- Surgical Innovation
Background:
- Cataract surgery aims to restore vision, but pre-existing astigmatism can complicate outcomes.
- Toric intraocular lenses (IOLs) are designed to correct astigmatism during cataract surgery.
- Transitioning to toric IOLs in non-refractive practices presents unique challenges.
Purpose of the Study:
- To identify challenges in adopting toric IOLs in a non-refractive cataract practice.
- To evaluate the effectiveness of toric IOLs in reducing residual astigmatism.
- To assess the impact of toric IOLs on patient satisfaction and visual functioning.
Main Methods:
- A single, non-refractive surgeon performed all cataract surgeries with toric IOLs.
- Pre-operative, intra-operative, and post-operative data were analyzed.
- Patient-reported outcomes, including visual functioning and satisfaction, were assessed using validated questionnaires.
Main Results:
- Median difference vector (DV) was 0.93D, significantly lower than the 2.38D anticipated with non-toric IOLs.
- One eye had 0.75D residual astigmatism, compared to an anticipated 3.8D with non-toric IOLs.
- 100% of patients reported satisfaction of ≥ 6/10, with 37.84% entirely satisfied; dysphotopsia symptoms were minimal.
Conclusions:
- Toric IOLs effectively manage astigmatism during cataract surgery, yielding less post-operative astigmatism than non-toric IOLs.
- This approach helps avoid unacceptable levels of post-operative astigmatism.
- Successful implementation in a non-refractive setting is achievable, enhancing patient outcomes.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K


